Astellas is a Top 20 global pharma company with operations in Japan, North America, EMEA (Europe, Middle East and Africa) and Asia/Oceania.
On the forefront of healthcare change, Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients worldwide.
Key therapeutic areas of focus; Oncology, Urology, Anti-infectives and Transplantation.
Everything Astellas does is guided by the company values and desire to be a trusted healthcare partner: Patient Focus, Ownership, Results, Openness and Integrity.
Focused on converting science into value for patients not only across our current areas of expertise, but also where innovation is poised to drive significant scientific advancements. Astellas continue to invest in core therapeutic areas, but also exploring new therapeutic areas, such as ophthalmology and muscle disease, as well as leading technologies, such as regenerative medicine and next-generation vaccines.
At Astellas, we are committed to the ethos of CHANGING TOMORROWTM.
For more information: https://www.astellas.eu/